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Abstract 5P-Fluorodeoxyadenosine synthase, a C^F bond-
forming enzyme, has been puri¢ed from Streptomyces cattleya.
The enzyme mediates a reaction between inorganic £uoride and
S-adenosyl-L-methionine (SAM) to generate 5P-£uoro-5P-deoxy-
adenosine. The molecular weight of the monomeric protein is
shown to be 32.2 kDa by electrospray mass spectrometry. The
kinetic parameters for SAM (Km 0.42 mM, Vmax 1.28 U/mg)
and £uoride ion (Km 8.56 mM, Vmax 1.59 U/mg) have been
evaluated. Both S-adenosyl-L-homocysteine (SAH) and sinefun-
gin were explored as inhibitors of the enzyme. SAH emerged as
a potent competitive inhibitor (Ki 29 WM) whereas sinefungin
was only weakly inhibitory.
6 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
In 1986 Sanada and co-workers reported the identi¢cation
of £uoroacetate and 4-£uorothreonine as secondary metabo-
lites of Streptomyces cattleya, when the bacterium was grown
in the presence of £uoride ion [1]. These metabolites are
among the very few known £uorine-containing metabolites
[2,3]. The toxin £uoroacetate is the most ubiquitous of the
£uorine-containing metabolites and has been identi¢ed in
over 40 plants with a global distribution [4]. Although some
tentative e¡orts have been made over the years to explore
£uoroacetate biosynthesis in plants, no substantial progress
has been made [4]. The identi¢cation of £uoroacetate and
4-£uorothreonine from a bacterium, however, presented a
more amenable biosynthetic system in which to study £uoro-
acetate biosynthesis [1,5]. As a result, a combination of isotopic
labelling studies and cell-free experiments with S. cattleya has
revealed some of the details of £uorometabolite biosynthesis
including the intermediacy of £uoroacetaldehyde as a com-
mon precursor to £uoroacetate and 4-£uorothreonine [6].
The enzymes between £uoroacetaldehyde and both metabo-
lites have been identi¢ed and puri¢ed [7,8]. Of particular sig-
ni¢cance, we have recently reported that the £uorination
process, in cell-free studies, involves a reaction between S-ad-
enosyl-L-methionine (SAM) and £uoride ion to generate
5P-£uoro-5P-deoxyadenosine (5P-FDA) [9]. This enzyme un-
usually generates a C^F bond and is the ¢rst formed product
in £uorometabolite biosynthesis in S. cattleya as summarised
in Fig. 1.
In this paper we report details of the puri¢cation and char-
acterisation of 5P-FDA synthase, the £uorination enzyme
from S. cattleya (Fig. 1).
2. Materials and methods
2.1. Materials
SAM and S-adenosyl-L-homocysteine (SAH) were purchased from
Sigma, UK. 5P-FDA was prepared as previously described [6].
2.2. Preparation of cell-free extract
Cells of S. cattleya NRRL 8057 were grown in conical £asks (500
ml) containing the medium (90 ml) as described by Reid et al. [5].
After 6 days incubation (28‡C, 180 rpm), the cells were harvested and
washed with Tris^HCl bu¡er (50 mM, pH 7.8) and resuspended in the
same bu¡er. The cell-free extract was prepared by sonication (5U1
min, 60% duty cycle) and centrifugation of the cell debris (20 000Ug
for 20 min at 4‡C). Typically the protein concentration was 2.6 mg/ml.
2.3. Enzyme assay
Enzymatic activity was assayed at 25‡C, monitoring 5P-FDA pro-
duction using a Waters HPLC system (Waters 2700 Sample Manager,
600 Controller, 2487 Dual Absorbance Detector and Fraction Collec-
tor II). Protein fractions (0.1 ml) were incubated at 37‡C with SAM
(0.2 mM) and KF (5.0 mM) in Tris^HCl bu¡er (50 mM, pH 7.8), in a
¢nal volume of 0.2 ml. Samples for HPLC analysis were boiled at
95‡C (3 min) and the precipitated protein was removed by centrifu-
gation. An aliquot (20 Wl) of the clear supernatant was used for HPLC
analysis on a Hypersil 5 WM C-18 column (250U4.6 mm, Macherey-
Nagel) equilibrated with KH2PO4 (50 mM) and acetonitrile (95:5
v/v). Runs were monitored at 260 nm by gradient elution from a
starting mobile phase of KH2PO4 (50 mM) and acetonitrile (95:5
v/v) to a ¢nal mobile phase consisting of KH2PO4 (50 mM) and
acetonitrile (80:20 v/v). Samples were introduced through a high-pres-
sure injector ¢tted with a 100 Wl loop and the £ow rate was main-
tained at 1.0 ml/min with a total time of elution of 20 min. The
concentration of 5P-FDA was determined against a standard curve
derived using synthetic 5P-FDA [6]. Protein concentrations were de-
termined using the Coomassie blue binding method [10].
2.4. Puri¢cation of 5P-FDA synthase
The enzyme activity was partially puri¢ed by adding solid
(NH4)2SO4 to cell-free extracts until 45% saturation and removing
the precipitate by centrifugation. The supernatant was adjusted to
60% saturation with solid (NH4)2SO4 and the precipitate was col-
lected after centrifugation. The pellet was then resuspended in Tris^
HCl bu¡er (50 mM, pH 7.8) with 1 M (NH4)2SO4, and the protein
eluted from a phenyl Sepharose HP (Amersham Pharmacia Biotech)
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column at 2 ml/min using an AKTA Prime FPLC system (Amersham
Pharmacia Biotech) (¢rst 40 ml Tris^HCl bu¡er with 1 M (NH4)2SO4
and then a linear gradient from 1 to 0 M (NH4)2SO4 in Tris^HCl
bu¡er (50 mM, pH 7.8) over a ¢nal volume of 80 ml). The active
fractions were concentrated (1.5 ml) using a 10 kDa Macrosep (Pall
Folton) centrifugal concentrator and the solution was applied to a
HiLoad 16/60 Superdex 200 gel ¢ltration column (Amersham Phar-
macia Biotech) with Tris^HCl bu¡er (50 mM, pH 7.8). The fractions
containing £uorination activity were pooled and subjected to a 10 ml
Source 15 Q strong anion exchange column (Amersham Pharmacia
Biotech) at 2 ml/min, with a linear gradient of 0^0.3 M KCl in Tris^
HCl over 80 ml. All puri¢cation steps were conducted at 4‡C.
3. Results
3.1. Puri¢cation analysis
The £uorination enzyme was puri¢ed to homogeneity fol-
lowing the procedure described in Section 2.4 and summarised
in Table 1, Fig. 2. Using this procedure the enzyme was pu-
ri¢ed 26-fold with an overall yield of 17%. As there was no
signi¢cant improvement in the level of purity between the gel
¢ltration and anion exchange steps, characterisation was gen-
erally carried out on protein recovered after gel ¢ltration
chromatography.
Analysis of the protein fractions by sodium dodecyl sul-
phate^polyacrylamide gel electrophoresis (SDS^PAGE) after
each puri¢cation stage is shown in Fig. 2.
3.2. Biochemical properties of 5P-FDA synthase
The molecular weight of the monomeric protein was esti-
mated to be around 32 kDa by SDS^PAGE; however, a more
accurate assessment (V32.2 kDa) of the molecular weight was
obtained by electrospray ionisation mass spectrometry (ESI-
MS). The resultant spectrum is shown in Fig. 3. Passing the
puri¢ed enzyme through a HiLoad 16/60 Superdex 200 gel
¢ltration column showed a native mass of approximately
180 kDa, indicating that this enzyme is probably a hexamer
in solution. The e¡ect of temperature on the enzyme was
investigated by conducting an assay over a range of temper-
atures from 25 to 70‡C. The temperature optimum was deter-
mined to be 55‡C. Addition of EDTA (1 mM) increased en-
zyme activity by 25%, indicating that the enzyme may be
sensitive to trace amounts of metal ions. However, the pres-
ence of Mg2þ ion (1 mM) did not a¡ect the activity.
The N-terminal amino acid sequence (24 amino acids) of
the puri¢ed synthase (determined using an Applied Biosys-
tems Procise 491 sequencing instrument) was found to be
Ala-Ala-Asn-Ser-Thr-Arg-Arg-Pro-Ile-Ile-Ala-Phe-Met-Ser-
Asp-Leu-Gly-Thr-Thr-Asp-Asp-Asp-Val-Gln.
3.3. Substrate speci¢city of 5P-FDA synthase
5P-FDA synthase utilises SAM and £uoride ion to generate
5P-FDA (Fig. 1). The kinetic parameters of the enzyme were
Fig. 1. Biotransformation of SAM and F3 to 5P-FDA in S. cattleya.
Table 1
Puri¢cation of the £uorination enzyme from S. cattleya
Puri¢cation step Total volume
(ml)
Total protein
(mg)
Speci¢c activity
(U/mg)
Total activity
(U)a
Puri¢cation
(fold)
Yield
(%)
Cell-free extract 100 263.34 0.055 14.5 1 100
Desalted (NH4)2SO4 fraction 10 72.77 0.14 10.2 2.5 70.3
Hydrophobic interactive 1.5 7.49 1.04 7.8 18.9 53.7
Gel ¢ltration 6 3.99 1.36 5.4 24.7 37.4
Anion exchange 8 1.73 1.44 2.5 26.2 17.2
aOne unit is de¢ned as the amount of enzyme required to synthesise 1 nmol of 5P-FDA per minute.
FEBS 27431 3-7-03
C. Scha¡rath et al./FEBS Letters 547 (2003) 111^114112
determined from Lineweaver^Burk plots. The assays were
conducted using a range of SAM concentrations (0.1^0.6
mM) while the £uoride ion concentration was kept constant
at 5 mM, and then a range of £uoride ion concentrations
(2.5^15 mM) while the SAM was held at 0.2 mM. The Km
value for SAM was calculated to be 0.42 mM (Table 2). The
Km value for £uoride ion was 20-fold higher than that for
SAM (8.56 mM), perhaps indicating a poor a⁄nity for the
enzyme. One possible explanation for this higher value may be
the well-known ability of £uoride ion to be readily solvated.
Clearly, this high energy of solvation requires to be overcome
for enzyme binding. Chloride ion was also explored in this
study up to 10 mM but was not a substrate or inhibitor of the
enzyme.
SAH (Fig. 4) has been reported to inhibit reactions of
SAM-dependent enzymes [11]. Therefore SAH was explored
as an inhibitor of the enzyme. In the event 5P-FDA produc-
tion was inhibited (95% loss of enzyme activity) when the
enzyme was incubated with SAM (0.4 mM), KF (10 mM)
and SAH (0.4 mM). The values derived from Lineweaver^
Burk plots indicated that SAH was a competitive inhibitor
of the enzyme with a Ki value of 29 WM. The antibiotic sine-
fungin (Fig. 4) is also known as an inhibitor of SAM-depen-
dent enzymes [12]. The presence of sinefungin (0.4 mM)
caused only 15% loss of enzyme activity after 1 h incubation
with SAM (0.4 mM) and KF (10 mM), indicating that it is a
weak inhibitor of this enzyme.
4. Conclusion
We report the puri¢cation of the ¢rst native £uorination
Fig. 2. SDS^PAGE of pooled fractions containing the £uorination
enzyme during each puri¢cation step. Lanes: 1, marker MBP-L-ga-
lactosidase (175 kDa), MBP-paramyosin (83 kDa), glutamic dehy-
drogenase (62 kDa), aldolase (47.5 kDa), triosephosphate isomerase
(32.5 kDa) and L-lactoglobulin A (25 kDa); 2, crude cell-free ex-
tract; 3, (NH4)2SO4 precipitate fractionation; 4, hydrophobic inter-
active chromatography; 5, gel ¢ltration; 6, anion exchange chroma-
tography.
Fig. 3. ESI-MS spectra (Micromass LCT) of the synthase obtained from infusion of a protein solution. The analytic sample was applied to a
HPLC (Waters 2795 LC unit) equipped with a guard column (Waters Xterra MS C8, 2.1U10 mm). A linear gradient of 2% solvent A (MeCN
and 2% formic acid) to 2% solvent B (water and 2% formic acid) at 0.2 ml/min was used.
Table 2
Kinetic parameters of substrates for enzymatic £uorination
Substrate Km (mM)a Vmax (U/mg)a
SAM 0.42b T 0.05 1.28b T 0.09
KF 8.56c T 0.52 1.59c T 0.13
aValues are the means of triple experiments; the variation around
the mean was no more than 8%.
b[SAM] varied from 0.1 to 0.6 mM with [F3] at 5 mM.
c[F3] varied from 2.5 to 15 mM with [SAM] at 0.2 mM.
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enzyme from an organism which has the capacity to biosyn-
thesise organo-£uorine compounds as secondary metabolites.
The enzyme mediates the ¢rst committed step in the biosyn-
thesis of £uoroacetate and 4-£uorothreonine in S. cattleya.
There are some other reports of enzymes which can process
£uoride ion and generate covalently bound £uorine. In 1957
Ochoa and co-workers demonstrated a ‘£uorokinase’ activity
which co-eluted with pyruvate kinase, and had the ability to
generate £uorophosphate from ATP and £uoride ion [13].
More recently the enzymatic synthesis of C^F bonds using
mutant glycosidase enzymes has been reported [14,15]. These
mutants were devoid of the key glutamate residue which sta-
bilises the oxonium intermediate and had that residue re-
placed by other amino acid residues after site-directed muta-
genesis e.g. by serine. These mutants generated glycosyl
£uorides when incubated with glycosyl-ODNP substrates
and £uoride ion at 2 M and clearly £uoride ion has inter-
cepted the activated intermediate to generate a C^F bond.
The present report outlines the isolation of an enzyme which
has evolved a capacity to generate C^F bonds as its primary
function. The over-expression of this enzyme and a fuller
evaluation of its mechanism are under study.
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